1. Black FT et al., Prophylactic Efficacy of Lactobacilli on Traveler’s Diarrhea. J Travel Med. 1989: 333-335.
2. Hilton et al., Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers. J Travel Med. 1997 Mar 1;4(1):41-43.
3. Rao et al., Diagnosis and management of chronic constipation in adults. Nat Rev Gastroenterol Hepatol. 2016 May;13(5):295-305.
4. Kim et al., Sex-Gender Differences in Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2018 Oct 1;24(4):544-558.
5. Eskesen et al., Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial. Br J Nutr. 2015 Nov 28;114(10):1638-46.
6. Pitkala et al., Fermented cereal with specific bifidobacteria normalizes bowel movements in elderly nursing home residents. A randomized, controlled trial. J Nutr Health Aging. 2007 Jul-Aug;11(4):305-11.
7. Uchida eet al., Effect of fermented milk containing bifidobacterium lactis BB-12 on stool frequency, defecation, fecal microbiota and safety of excessive ingestion in healthy female students. Journal of Nutritional Food, 2005 8, 39-51.
8. Nishida ete al., Effect of yoghurt containing Bifidobacterium lactis BB-12 on improvement of defaecation and faecal microflora of healthy female adults., 20043163374, Japanese, Journal article, Japan, 1343-0289, 53, (2), Sendai-shi, Milk Science, (71–80), Japanese Dairy Science Association, (2004).
9. Matsumoto et al., Impact of LKM512 yogurt on improvement of intestinal environment of the elderly. FEMS Immunol Med Microbiol. 2001 Oct;31(3):181-6. 10. Shioya, et al. Effect of fermented milk containing Bifidobacterium lactis FK 120 on the fecal flora, with special reference to Bifidum species, and fecal properties in healthy volunteers. Food Health and Nutrition Research (Journal of Nutritional Food) 2000:19-32.
11. Armuzzi et al., The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther. 2001 Feb;15(2):163-9.
12. Armuzzi et al., Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion. 2001;63(1):1-7.
13. Cremonini et al., Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol. 2002 Nov;97(11):2744-9.
14. Hauser et al., Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial. Medicine (Baltimore). 2015 May;94(17): e685.
15. Chatterjee et al., Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea. J Assoc Physicians India. 2013 Oct;61(10):708-12.
16. de Vrese eet al., Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity. J Dairy Res. 2011 Nov;78(4):396-403.
17. Sorensen et al. (2026) submitted.
18. Mehta et al. A study of probiotic Bacillus subtilis HU58 for the management of antibiotic associated-diarrhoea in adults. The Indian Practitioner. 2020; 73(4):22-b.
19. Mehta et al. An open labeled, placebo controlled trial to evaluate the role of probiotics – Bacillus subtilis HU58 and Bacillus coagulans SC208 on antibiotic associated diarrhoea in humans.Biomed J Sci Tech Res. 2020: 29(4):22679-22684.